Skip to main content

Table 2 Effects of rosiglitozane on MDA content and SOD activity (n = 5)

From: PPAR-alpha and PPAR-beta expression changes in the hippocampus of rats undergoing global cerebral ischemia/reperfusion due to PPAR-gamma status

Group

SOD

MDA

 

(ng/ml)

(ng/ml)

sham control

71.58 ± 6.23

1.74 ± 0.14

IR

37.24 ± 5.16**

2.33 ± 0.19**

0.8 mg/kg Ros

40.37 ± 4.32**

2.14 ± 0.15**

2.4 mg/kg Ros

49.37 ± 7.25**##

1.97 ± 0.17*##

7.2 mg/kg Ros

55.47 ± 9.31##

1.89 ± 0.21##

7.2 mg/kg Ros plus GW9662

35.31 ± 6.11**

2.44 ± 0.17**

GW9662 in sham control

69.43 ± 4.57

1.83 ± 0.24

  1. Datas are expressed as mean ± SD (n = 5). * and **:P < 0.05 and 0.01, vs. sham control; # and ##:P < 0.05 and 0.01 vs. IR.